The first successful gene therapy—modifying a person’s DNA to treat disease—occurred in 1990. In the nearly three decades since those pioneering treatments, there are thousands of gene therapy studies and… Read more
Posted by Wayne Embree in #Startup Buzz
In medicine, pathologists are known as the doctors’ doctors. Whether the task at hand is to diagnose an individual patient or to study the influence of a particular cell on… Read more
Posted by Wayne Embree in #Startup Buzz
$5.5MM Life Sciences Fund Propels Research-Based Startups from The Research Institute at Nationwide Children’s Columbus, OH—September 20, 2016—Today, Rev1Ventures, the seed-stage venture fund that combines investment capital and strategic services,… Read more
Posted by Tom Walker in Rev1 News & Events
Finding a treatment for an incurable disease is the Holy Grail of bioscience research. And the modern day quest is every bit as inspiring as the Arthurian legends—especially to families… Read more
Posted by Rev1 Staff in Success Stories
Investment in Milo Biotechnology marks milestone in strategic relationship. Rev1 Ventures and Nationwide Children’s Hospital combine forces to help a promising life science spinout deliver a new gene-based therapy to… Read more
Posted by Rev1 Staff in Rev1 News & Events
